Abstract

IntroductionMortality and disability in diabetes mellitus are determined mostly by cardiovascular complications and cancer. The impact of dipeptidyl peptidase-4 inhibitor (DPP-4i) and sodium-glucose cotransporter-2 inhibitor (SGLT2i) monotherapy or combination on...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes.
Jiandong Zhou ... Fengshi Jing
Rheumatology (Oxford, England) | VOL. 62
Jiandong Zhou, et. al.Jiandong Zhou ... Fengshi Jing
06 Sep 2022
The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation
S H Shin ... J H Jang
European heart journal | VOL. 44
S H Shin, et. al.S H Shin ... J H Jang
09 Nov 2023
Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus.
Yuya Seko ... Tasuku Hara
International Hepatology Communications | VOL. 47
Yuya Seko, et. al.Yuya Seko ... Tasuku Hara
07 Dec 2016
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database.
Takanori Imai ... Shuji Hatakeyama
Diabetes Therapy | VOL. -
Takanori Imai, et. al.Takanori Imai ... Shuji Hatakeyama
03 Jul 2024
View more papers

More From: BMJ open diabetes research & care

Paper Title
Journal
Date
Author
Assessing the use of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and chronic kidney disease in tertiary care: a SwissDiab Study
Pascale Sharon Hösli ... Michael Brändle
BMJ open diabetes research & care | VOL. 12
Pascale Sharon Hösli, et. al.Pascale Sharon Hösli ... Michael Brändle
19 Jun 2024
Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT) in Chinese patients with young-onset diabetes: design, methods and baseline characteristics
Chun Kwan O ... Juliana C N Chan
BMJ open diabetes research & care | VOL. 12
Chun Kwan O, et. al.Chun Kwan O ... Juliana C N Chan
19 Jun 2024
Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals
Mehrdad A Mizani ... Amitava Banerjee
BMJ open diabetes research & care | VOL. 12
Mehrdad A Mizani, et. al.Mehrdad A Mizani ... Amitava Banerjee
01 Jun 2024
A randomized, placebo-controlled study of chitosan gel for the treatment of chronic diabetic foot ulcers (the CHITOWOUND study)
Matevž Slivnik ... Vilma Urbančič Rovan
BMJ open diabetes research & care | VOL. 12
Matevž Slivnik, et. al.Matevž Slivnik ... Vilma Urbančič Rovan
01 Jun 2024
View more papers